This trial is !
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Malignant Neoplasms of Digestive Organs or Metastatic Liver Tumors
and you are
over 18
years old
-
The phase for this study is not defined.
Show me locations

The purpose

You are being asked to take part in this study because you have liver cancer or cancer that has spread to the liver are scheduled for SIR-Spheres treatment (Yttrium-90 radioembolization treatment). The goal of this clinical research study is to learn about the safety of giving SIR-Spheres treatment to patients with liver cancer in the same session rather than over 2 sessions, which is the standard of care. This is an investigational study. The SIR-Spheres is delivered using FDA approved and commercially available methods. It is investigational to learn if the procedure can be safely performed in a single session. Up to 12 participants will be enrolled in this study. All will take part at MD Anderson.

Provided treatments

  • Device: SIR-Spheres
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03028311. The sponsor of the trial is M.D. Anderson Cancer Center and it is looking for 12 volunteers for the current phase.
Official trial title:
Feasibility of Single Session In-Room Yttrium-90 Radioembolization Diagnostic Angiography and Treatment